Dialysis firm DaVita misses third-quarter profit estimates on higher costs (updated)

Davita

29/10/2024 20:26

(Adds shares in paragraph 2, details about results in
paragraphs 4-6)
       Oct 29 (Reuters) - 
    Dialysis firm DaVita  DVA.N  reported third-quarter profit
that missed Wall Street estimates on Tuesday, hurt by high
patient care costs.
        Shares of the company were down 7.1% at $147 after the
bell.
  
    On an adjusted basis, it reported third-quarter profit of
$2.59 per share, below analysts' estimate of $2.73 per share, as
per data compiled by LSEG.
        The company reiterated its annual profit forecast of
$9.25 and $10.05 per share.
  
        DaVita posted quarterly revenue of $3.26  billion,
largely in line with analysts' estimates of $3.25 billion. 
  
        DaVita provides kidney care services to patients
suffering from chronic kidney failure in the United States
through a network of outpatient clinics and at-home dialysis
services. 
  

    

 (Reporting by Sneha S K; Editing by Maju Samuel)
 ((Sneha.SK@thomsonreuters.com;))